- Published at
- by seekingalpha.com
negative
negative
Medigene pulls plug on MDG1021 development program (OTCMKTS:MDGEF)
Clinical stage immuno-oncology company Medigene AG (OTCPK:MDGEF) announces the discontinuation of its blood cancer treatment MDG1021's development program, as it looks to focus on the...